why choose us

First received: May 26, 2023

Clinical Trial: A Biomarker Screening Protocol for Participants With Solid Tumors

Study Status: Completed

Recruit Status: RECRUITING

Condition: Triple Negative Breast Cancer

Study Type: OBSERVATIONAL


Official Title: A Biomarker Screening Protocol to Support Preliminary Eligibility for Clinical Trials Evaluating Safety and Efficacy of Adoptive T-cell Therapies in Participants With Solid Tumors

Brief Summary: Biomarker Screening Protocol for Preliminary Eligibility Determination for Adoptive T-cell Therapy Trials:This is a decentralized, multi-site, US-based biomarker screening study to identify participants who have specific disease indications and tumor expression of target(s) of interest that may inform eligibility for active and future Lyell clinical trials.No investigational treatments will be administered in this non-interventional screening study.Only previously obtained archival tumor tissue will be allowed on…

Read more